Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$MRNA Q1 '25 Earnings Results & Recap
Moderna reported Q1 revenue of $108 million (vs. $106.18M estimate) and a net loss of $1 billion. The firm's loss per share was better than expected, -$2.52, vs. -$3.12 estimate. The company expects full-year revenue between $1.5B and $2.5B, with the flu/COVID combination vaccine approval delayed to 2026.4
